Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide.

BACKGROUND: Soft tissue sarcoma (STS) is an anatomically and histologically heterogeneous neoplasia that shares a putative mesenchymal cell origin. The treatment with common chemotherapeutics is still unsatisfying because of association with poor response rates. Although evidence is accumulating for...

Full description

Bibliographic Details
Main Authors: Lars Steinstraesser, Jennifer Hauk, Cornelius Schubert, Sammy Al-Benna, Ingo Stricker, Hanns Hatt, Yechiel Shai, Hans-Ulrich Steinau, Frank Jacobsen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3069083?pdf=render